Trial Profile
Zoetermeer Study: double-blind randomised, placebo-controlled clinical study to investigate the effects of daily oral atamestane (100 mg/day) and dehydroepiandrosterone (50 mg/day) alone and in a combined regimen on physical frailty and quality of life in 100 elderly male volunteers over a treatment period of 36 weeks.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2009
Price :
$35
*
At a glance
- Drugs Atamestane (Primary) ; Prasterone (Primary)
- Indications Musculoskeletal disorders
- Focus Pharmacodynamics
- 04 Feb 2009 New trial record